"10.1371_journal.pone.0152034","plos one","2016-03-31T00:00:00Z","Michael T Zimmermann; Ann L Oberg; Diane E Grill; Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Gregory A Poland","Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America","Conceived and designed the experiments: MTZ ALO DEG IGO IHH RBK GAP. Performed the experiments: IGO IHH RBK. Analyzed the data: MTZ ALO DEG IGO IHH RBK GAP. Contributed reagents/materials/analysis tools: GAP MTZ ALO. Wrote the paper: MTZ ALO DEG IGO IHH RBK GAP.","Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Kennedy has received funding from Merck Research Laboratories to study waning immunity to mumps vaccine. Dr. Poland offers consultative advice on vaccine development to Merck & Co. Inc., CSL Biotherapies, Avianax, Dynavax, Novartis Vaccines and Therapeutics, Emergent Biosolutions, Adjuvance, and Microdermis. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","03","Michael T Zimmermann","MTZ",7,TRUE,7,3,7,7,TRUE,TRUE,FALSE,0,NA,FALSE
